When I first invested it was for HIV. The science was
When I first invested it was for HIV. The science was there. Google the Berlin Patient for the root of this story. The safety profile was what convinced me to invest.
The risks were immense. And my initial investment was small. The share price ground down under 50 cents on dilution. But more and more data came out in other indications that a ccr5 antagonist could treat. As more indications presented, I increased my holding. Once cancer became a likely target I invested a large chunk of money directly with the company in order to get warrants in addition to my shares.
It wasn't a guess. A gamble? Maybe. But a well educated one at that.
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...
Continue Reading
The Folding Bike Revolution: More Than Just a Fad You've seen them zipping around—those compact, folding bikes. They're not just for urban commuters looking to save space. Oh no, this is a full-blown cycling revolution we're talking about. DAHON, a name that's been rolling since 1982, has been riding these waves and making strides that others can only dream of. While...
Continue Reading
The AI Mentor Battleground in Education Ever found yourself wondering how public schools could step up their game without dumping money down the tech rabbit hole? ETERC’s latest push with Ele may just be a game-changer for them. We're not talking about your run-of-the-mill chatbot regurgitating facts from the internet—this is an AI tricked out for personalized...
Continue Reading
New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...
Continue Reading
Wounded Warriors Gala: A Night of Heroic Honors In the swirling hum of Washington's gala scene, the Wounded Warrior Project (WWP) cuts through the noise with a sharp and poignant reminder of patriotism and community support. Their Courage Awards & Benefit Dinner®, pumped with the gravitas of corporate backing from the likes of Goldman Sachs, showcased a heartfelt...
Continue Reading
Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...
Continue Reading
Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...
Continue Reading
End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...
Continue Reading
Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...
Continue Reading
Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...
Continue Reading
Top 5 Most Recently Viewed Articles
FirstBank's Q2 Performance Overview FirstBank, known as one of the nation's largest privately held banks, recently shared an impressive financial report that highlights its significant achievements in the second quarter of 2025. The bank has firmly established itself with a commitment to 'banking for good', and its recent results reflect this dedication to both its...
Continue Reading
Murphy Oil Corporation Announces Senior Notes Offering Murphy Oil Corporation (NYSE: MUR) has announced plans to issue $600 million in Senior Notes, which will mature in 2032. This initiative is part of the company’s ongoing efforts to strengthen and solidify its financial position. Details of the Senior Notes Offering The Senior Notes will feature a fixed interest rate...
Continue Reading
Earnings Overview for Innovative Solns Innovative Solns (NASDAQ: ISSC) is set to announce its quarterly earnings report soon, stirring excitement among investors. With many expecting solid results, this report holds significant importance for both current and potential shareholders. Projected Earnings Per Share Analysts have set the bar for Innovative Solns at an...
Continue Reading
Linear Integrated Systems Introduces Innovative JFETs Linear Integrated Systems, a prominent player in the semiconductor industry, has launched a collection of ultra-low-noise JFETs that offer guaranteed low noise performance. These components are crucial for various applications, particularly in Analog Front-Ends, Discrete Op Amps, and Low Noise Amplifiers, where...
Continue Reading
Genetic Profiles and Treatment Efficacy in Blood Cancers Recent research has unveiled crucial genetic factors that could revolutionize treatment strategies for patients suffering from myeloproliferative neoplasms, conditions such as polycythemia vera (PV) and essential thrombocythemia (ET). These findings, highlighted at a key hematology conference, indicate that specific...
Continue Reading